Echo, a medication management app, has closed a £1.8m Seed round led by LobalGlobe. Global Founders Capital also participated in the round.
Born out of a frustration with the confusing repeat prescription system, Echo allows users to request prescriptions via the app, which are then sent to their existing NHS GP for approval.
Stephen Bourke, co-founder of Echo, explained: “There are too many barriers to obtaining a repeat prescription, from having to take time off work to attend a GP appointment, to the pharmacy not having enough medication in stock.
“Echo brings the whole process to your smartphone, with delivery to your door.”
The London-based HealthTech firm plans to use the funds to improve product and user experience by investing in new talent.
Sai Lakshmi co-founder and CEO of Echo, commented: “This investment is testament to how hard our team has worked over the past year and how urgently the NHS needs practical, frontline innovation. Our investors have been brilliant, coaching the team, opening doors and getting stuck to the detail of our industry.
“HealthTech has to start with the end-user, and in 2016 they expect a seamless service. Amazon and Apple provide the benchmarks. This requires a massive investment in people, and we are immediately looking to make another eight hires across engineering, design and operations,” he concluded.